The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lanfear Dennis M since 2015.
This trader's CIK number is 1420822.
At the time of last reporting, Lanfear Dennis M was the President & CEO of Coherus Biosciences, Inc.. (stock ticker symbol CHRS).
Also see all insider trading activities at Coherus Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | CHRS | 0 | $0 | 223,100 | $449,769 | 299,940 | $425,014 |
| 2021 | CHRS | 0 | $0 | 31,054 | $421,216 | 331,054 | $138,049 |
| 2020 | CHRS | 0 | $0 | 0 | $0 | 29,994 | $239 |
| 2019 | CHRS | 0 | $0 | 869,898 | $15,713,237 | 0 | $0 |
| 2018 | CHRS | 0 | $0 | 20,984 | $341,262 | 0 | $0 |
| 2016 | CHRS | 0 | $0 | 6,960 | $221,107 | 0 | $0 |
| 2015 | CHRS | 0 | $0 | 400 | $12,700 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-11-22 | CHRS | Option Ex | 299,940 | 1.42 | 425,014 |
| 2023-11-22 | CHRS | Sale | 223,100 | 2.02 | 449,769 |
| 2021-06-06 | CHRS | Option Ex | 300,000 | .42 | 125,100 |
| 2021-06-08 | CHRS | Option Ex | 31,054 | .42 | 12,949 |
| 2021-06-08 | CHRS | Sale | 31,054 | 13.56 | 421,216 |
| 2020-07-01 | CHRS | Option Ex | 29,994 | .01 | 239 |
| 2019-11-21 | CHRS | Sale | 12,500 | 18.56 | 231,962 |
| 2019-11-20 | CHRS | Sale | 825,000 | 18.00 | 14,850,000 |
| 2019-05-30 | CHRS | Sale | 32,398 | 19.48 | 631,275 |
| 2018-05-16 | CHRS | Sale | 20,984 | 16.26 | 341,262 |
| 2016-09-20 | CHRS | Sale | 4,010 | 31.75 | 127,321 |
| 2016-09-21 | CHRS | Sale | 50 | 31.75 | 1,587 |
| 2016-09-16 | CHRS | Sale | 2,900 | 31.79 | 92,199 |
| 2015-11-30 | CHRS | Sale | 400 | 31.75 | 12,700 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lanfear Dennis M (President & CEO of Coherus Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.